| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a8e20137e10efebd66f7b326dc42151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c380acd1e662aa64f4eb7c229a6525a |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 |
| filingDate |
2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e9c4c592d580ef597c2398cdf53be87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9048fd6fd00093b865543ab565b0bb4f |
| publicationDate |
2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201716445-A |
| titleOfInvention |
Immunoglobulin fusion protein |
| abstract |
The disclosed is a fusion protein comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain linked to the biologically active molecule. The Fc domain is (i) IgGl, IgG2 or IgG4 or (ii) a heterozygous human Fc domain of IgG4 and IgD. This hybrid Fc is useful as a carrier for biologically active molecules. |
| priorityDate |
2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |